Estoque drrx yahoo

12/01/2020 · Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

View live DURECT CORP chart to track its stock's price action. Find market predictions, DRRX financials and market news. 07/03/2019 · DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis. DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis. 12/01/2020 · DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis. DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis. 12/01/2020 · Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. 10/01/2020 · Discover historical prices for DRRX stock on Yahoo Finance. View daily, weekly or monthly format back to when DURECT Corporation stock was issued.

04/11/2019 · Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest DURECT Corporation (DRRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Add DRRX Price Alert Hide Sticky Hide Intro Moderator: BooDog Search This Board: 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+ At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. 12/12/2019 · Get the latest DURECT Corporation (DRRX) stock news and headlines to help you in your trading and investing decisions.

12/01/2020 · DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis. DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis.

09/01/2020 · Get the latest DURECT Corporation (DRRX) stock news and headlines to help you in your trading and investment decisions. Search the world's information, including webpages, images, videos and more. Google has many special features to help you find exactly what you're looking for.

Find out the direct holders, institutional holders and mutual fund holders for DURECT Corporation (DRRX).

07/03/2019 · DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis. DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis. 12/01/2020 · DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis. DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis. 12/01/2020 · Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Pessoas do Yahoo quando todos morrer vcs vão deixar seus legados aqui para as próximas gerações? Seus legados serão suas mensagens aqui que ficaram gravadas para sempre então qual msg vc deixaria para as próximas gerações que virão fazer parte do Yahoo seja os pirralhos ou n adultos ou n

08/01/2020 · Interactive chart for DURECT Corporation (DRRX) – analyse all of the data with a huge range of indicators. Find the latest DURECT Corporation (DRRX) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

12/01/2020 · DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis. DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis. 12/01/2020 · Shares of drug developer Durect Corp. shed nearly a third of their value Thursday after the Cupertino company said its headline drug failed a mid-stage clinical trial aimed at people with itchy, scaly psoriasis. Durect's drug, called DUR-928, has been closely watched not only because of of the At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.